GP and patient predictors of PSA screening in Australian general practice

Family Practice

Volumn 20, Issue 3, 2003, Pages 294-303

  Gattellari, Melina ^a,b   Young, Jane M ^b,c   Ward, Jeanette E ^a  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CENTRAL SYDNEY AREA HEALTH SERVICE   (Australia)

Author keywords

Evidence based practice; General practice; PSA screening

Indexed keywords

CHOLESTEROL; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; AUSTRALIA; CHI SQUARE TEST; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONSULTATION; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DIAGNOSTIC TEST; DISEASE SEVERITY; FAMILY MEDICINE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTAL MAIL; POSTGRADUATE EDUCATION; PREDICTION; PROSPECTIVE STUDY; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING TEST; SYMPTOMATOLOGY; URETHRA DISEASE;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; FAMILY PRACTICE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEW SOUTH WALES; PREVENTIVE MEDICINE; PROFESSIONAL PRACTICE; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 0038347270     PISSN: 02632136     EISSN: None     Source Type: Journal    
DOI: 10.1093/fampra/cmg311     Document Type: Article

References (33)

1. Smith D. Prostate Cancer in New South Wales in 1972-1994. Sydney: Cancer Council of New South Wales, 1998.
2. Ries L, Eisner M, Kosary C et al. SEER Cancer Statistics Review, 1973-1997. (NH publication number 00-2789). Bethseda (MD): National Cancer Institute, 2000.
3. Smith DP, Armstrong BK, Saunders R. Patterns of Prostate Specific Antigen (PSA) Testing in Australia in 1992 to 1996; An Examination of Medicare Data. Sydney: MSW Cancer Council, 1998.
4. Beemsterboer P, Kranse R, de Koning HJ, Habbema, JD, Schröder FH. Changing role of three screening modalities in the European randomized study of screening for prostate cancer. Int J Cancer 1999; 84: 437-441.
5. Schroder FH, Krause R, Rietbergen J, Hoedemaeke R, Kirkels W. The European Randomized Study of Screening for Prostate Cancer (ERSPC): an update. Members of the ERSPC, Section Rotterdam. Eur Urol 1999; 35: 539-543.
6. Ferrini R, Woolf SH. American College of Preventive Practice Policy: screening for prostate cancer in American men. Am J Prev Med 1998; 15: 81-84.
7. British Association of Urological Surgeons Working Party. Diagnosis and management of early prostate cancer. Report of a British Association of Urological Surgeons Working Party. BJU Int 1999; 83: 18-33.
8. Donovan J, Mills N, Smith M et al. Quality improvement report: improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Br Med J 2002; 325: 766-770.
9. Slevin TJ, Donnelly N, Clarkson JP, English DR, Ward JE. Prostate cancer testing: behaviour, motivation and attitudes among Western Australian men. Med J Aust 1999; 171: 185-188.
10. Bunting PS, Goel V, Williams JI, Iscoe NA. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer. Can Med Assoc J 1999; 160: 70-75.
11. Commonwealth Department of Health and Aged Care. General Practice in Australia, 2000. Canberra: Australian Government Printing Service, 2000.
12. Young JM, D'Este C, Ward JE. Improving family physicians' use of evidence-based smoking cessation strategies: a cluster randomization trial. Prev Med 2002; in press.
13. Ware J. MOS SF36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute, 1993.
14. Barry MJ, Fowler FJ Jr, O'Leary MP et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549-1557.
15. Lawrence K. Measurement properties of the AUA symptom score: a methodological clarification. Br J Urol 1996; 77: 175-180.
16. Gray M. Psychometric evaluation of the international prostate symptom score. Urol Nurs 1998; 18: 175-183.
17. Hosmer DW, Lemeshow S. Applied Logistic Regression. Brisbane: John Wiley and Sons, 2001.
18. Norusis JM/SPSS Inc. SPSS for Windows-based System User's Guide Release 9.0. Chicago: SPSS Inc., 1999.
19. NHMRC. Clinical Practice Guidelines: The Management of Uncomplicated Lower Urinary Tract Symptoms in Men. Canberra: Australian Government Printing Service, 2000.
20. Jocobsen SJ, Girman CJ, Guess HA, Rhodes T, Osterling JE, Leiber MM. Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men. J Urol 1996; 15: 595-600.
21. SAS Institute. SAS Procedures Guide, Version 8.0. North Carolina: SAS Institute, 1999.
22. Ward J, Young J, Sladden M. Australian general practitioners' views and use of tests to detect early prostate cancer. Aust NZ J of Public Health 1998; 22: 374-380.
23. Public Health Division. The Health of the People of New South Wales-Report of the Chief Health Officer, 2002. Sydney: NSW Department of Health, 2002.
24. Girgis S, Ward JE, Thomson CJH. General practitioners' perceptions of medicolegal risk. Using case scenarios to assess the potential impact of prostate cancer screening guidelines. Med J Aust 1999; 171: 362-366.
25. Austin OJ, Valente S, Hasse LA, Kues JR. Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians. Arch Fam Med 1997; 6: 453-458.
26. Wolf AM, Nasser JF, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med 1996; 156: 1333-1336.
27. Rolfe IE, Pearson SA. Screening recommendations in general practice: a survey of graduates from different medical schools. Med J Aust 1996; 165: 14-17.
28. Pathology Services Tables Committee. Report on the use of the prostate specific antigen (PSA) test April 2000 http://www.health.gov.au/haf/branch/dtb/psa.htm Last accessed June 12, 2002.
29. Young JM, Muscatello DJ, Ward JE. Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence. BJU Int 2000; 85: 1037-1048.
30. Jordan TR, Price JH, King KA, Masyk T, Bedell AW. The validity of male patients' self-reports regarding prostate cancer screening. Prev Med 1999; 28: 297-303.
31. O'Dell KJ, Volk RJ, Cass AR, Spann SJ. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions? J of Fam Pract 1999; 48: 682-688.
32. Driver B, Britt H, O'Toole B, Harris M, Bridges-Webb C, Neary S. How representative are patients in general practice morbidity surveys? Fam Pract 1991; 8: 261-268.
33. Stange KC, Zyzanski SJ, Smith TF et al. How valid are medical records and patient questionnaires for physician profiling and health services research? A comparison with direct observation of patients visits. Med Care 1998; 36: 851-867.